Early West Bengal election trends putting BJP ahead of TMC have pushed stocks like Bandhan Bank, CESC, and Berger Paints into focus. Invest...

Indian markets experienced significant volatility, closing flat-to-positive after a sharp recovery. Analysts anticipate continued fluctuati...

Emami Limited is gearing up to take the reins of Axiom Ayurveda Private Limited in a strategic acquisition that underscores its ambition in...

Emami Agrotech has launched the “Healthy & Tasty – FOR CHEF” range at AAHAR 2026 in New Delhi, targeting the hotel, restaurant and catering...

Emami Ltd., incorporated in the year 1983, is a Mid Cap company (having a market cap of Rs 32726.59 Crore) operating in FMCG sector.

Emami Ltd., incorporated in the year 1983, is a Mid Cap company (having a market cap of Rs 19199.45 Crore) operating in FMCG sector.

Emami Ltd., incorporated in the year 1983, is a Mid Cap company (having a market cap of Rs 20231.78 Crore) operating in FMCG sector.

Emami Ltd. key Products/Revenue Segments include Personal Care and Other Operating Revenue for the year ending 31-Mar-2022.

Emami Ltd., incorporated in the year 1983, is a Mid Cap company (having a market cap of Rs 23741.06 Crore) operating in FMCG sector.

The indicative maximum number of equity shares to be bought back under the buyback scheme would be over 41.33 lakh equity shares representi...

"We are very happy to announce the acquisition of Dermicool brand, which offers great synergy with our existing businesses and is a perfect...

The board also approved a buyback of shares of the company’s fully paid-up equity shares for an aggregate amount not exceeding Rs 162 crore...

The Kolkata-based conglomerate is joining tycoons including Anil Ambani & Subhash Chandra in selling assets to pare debt as a cash crunch i...

Emami has been a trending stock. In the last three months Emami has appreciated by about 20% plus.

There has been a bit of a spike in the last 1 month but that is not sufficient to get into the Emami Paper.

Emami's unsuccessful attempt to acquire Paras Pharma may boost its short-term outlook, but the development will put pressure to identify ot...